QLGN Stocktwits, News and Mentions. Forecasting Qualigen Therapeutics, Inc. Sentiments
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for QLGN stock
QLGN dividend
Qualigen Therapeutics, Inc. Analysis
QLGN Stock News


Popular stocks:
Suncor Energy
Tilray
QUALCOMM
Etsy

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
Toll Brothers
CF Acquisition
Siemens Energy
Tattooed Chef
The Mosaic Company
Delta Air Lines
Ollie's Bargain Outlet Holdings
Standard Lithium
Mimecast Limited
The Kraft Heinz Company


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Company News and Mentions
    3. »
  3. QLGN

QLGN Stock News and Mentions of Qualigen Therapeutics, Inc. Stocktwits

Updated: April 25, 2024 (13:15)

Sector: Healthcare

Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.

We meticulously analyze the sentiment trend in each article for the last 60 days where Qualigen Therapeutics Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Qualigen Therapeutics, Inc. (QLGN).

You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Qualigen Therapeutics stocks.

Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles

News and Mentions of Qualigen Therapeutics, Inc. (QLGN)

April 16, 2024 (11:00) / "GlobeNewswire" (by Marizyme Inc.)

Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
JUPITER, FL, April 16, 2024 ( GLOBE NEWSWIRE ) -- via NewMediaWire -- Marizyme, Inc. ( "Marizyme", OTCQB: MRZM ) announces today a Co-Development Agreement ( the "Agreement" ) with Qualigen Therapeutics, Inc. ( "Qualigen" ) ( NASDAQ: QLGN ) to advance the commercialization of Marizyme's ...
In Article Trend: Somewhat-Bullish
April 10, 2024 (12:00) / "GlobeNewswire" (by Inc.)

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research ( AACR ) 2024 Annual Meeting
Poster Includes Preclinical Data on Novel Direct Pan-RAS Inhibitors ...
In Article Trend: Neutral
April 9, 2024 (12:00) / "GlobeNewswire" (by Qualigen Therapeutics)

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research ( AACR ) 2024 Annual Meeting
CARLSBAD, Calif., April 09, 2024 ( GLOBE NEWSWIRE ) -- Qualigen Therapeutics, Inc. ( "Qualigen" or the "Company," Nasdaq: QLGN ) today announces that a poster featuring its early clinical experience with a novel first-in-class G-Quadruplex experimental anti-cancer drug, QN-302, was presented at ...
In Article Trend: Neutral



Related stocks from Healthcare sector

Atara Biotherapeutics, Inc. (ATRA)
Alkermes plc (ALKS)
SIGA Technologies, Inc. (SIGA)
CVS Health Corp. (CVS)
Allakos Inc. (ALLK)
Schrodinger, Inc. (SDGR)
Calliditas Therapeutics AB (publ) (CALT)
AbbVie Inc. (ABBV)
Biogen Inc. (BIIB)
Mirati Therapeutics, Inc. (MRTX)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website